It was reported by (b)(6), an onkos distributor, that a 55-year-old female patient underwent a revision surgery to address an alleged infection.The surgery took place on (b)(6) 2024 and is the second revision surgery for this patient in which eleos devices were revised.At the time of this revision surgery, the then 55-year-old female patient with an eleos total femur replacement had nine (9) eleos components explanted and replaced except for the femoral head which was replaced with a non-onkos device.
|
The root cause of this complaint was not determined.Based on the review of device history records, the investigation concluded that the root cause of the alleged infection was not related to the design, manufacture, and/or sterilization of previously implanted eleos implants.The following mdrs are related to this adverse event: 3013450937-2024-00073, 3013450937-2024-00074, 3013450937-2024-00075, 3013450937-2024-00076, 3013450937-2024-00077, 3013450937-2024-00078, 3013450937-2024-00079, and 3013450937-2024-00080.
|